23andMe: Personal Genetic Tests Provide 'Incomplete View' Of Disease Risk, Experts Say

By Rachael Rettner, Senior Writer Published: 11/26/2013 03:17 PMEST on LiveScience A major shortcoming of the genetic tests offeredby the Google-backed company 23andMe is not necessarily theiraccuracy, but rather the limited information they use to evaluate aperson's lifetime risk of complex diseases, experts say. Recently,the Food and Drug Administration sent a letter to 23andMe tellingthe company to stop marketing its DNA testing kits, because thekits require FDA approval, which the company had not obtained. Theletter emphasizes the need for 23andMe to prove that their testsare accurate. ...

via Health News Headlines - Yahoo! News http://www.huffingtonpost.com/2013/11/26/23andme-genetic-tests-disease-risk_n_4345867.html?ncid=txtlnkusaolp00000592